Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-30 @ 9:23 PM
Study NCT ID:
NCT05279456
Status:
COMPLETED
Last Update Posted:
2025-09-17
First Post:
2022-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
Sponsor:
Vaxine Pty Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-07
First Submit QC Date:
None
Study First Post Date:
2022-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-16
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED